Myrrh Woman
FDA Label NDC 72263-0002

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Mir Biotechnology for the product Myrrh Woman (NDC 72263-0002). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, otc - purpose, warnings, otc - keep out of reach of children, indications & usage, dosage & administration, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

menthol

Inactive Ingredient

sodium sulfate, niacinamide, olive leaf, adenosine, etc

Otc - Purpose

Cold odor Trichomonas candida infection treatment

Lack of come secretion

Vaginal cold urinary incontinence

Insensitivity to orgasms

Dry, rub and scar of Y zone

Lack of vaginal elasticity

Menopausal hormone imbalance

Lack of libido

Warnings

1. If the following symptoms occur after product use, stop using the product immediately and consult a dermatologist (continuous use can exacerbate the symptoms).
1) Occurrence of red spots, swelling, itchiness, and other irritation
2) If the symptoms above occur after the application area is exposed to direct sunlight

2. Do not use on open wounds, eczema, and other irritations
3. Precaution for Storage and Handling
1) Close the lid after use
2) Keep out of reach of infants and children
3) Do not to store in a place with high/low temperature and exposed to direct sunlight

4. Use as avoiding eye areas.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.

Indications & Usage

Wash the Y zone thoroughly, then put the Woman Essence in a pill and put it deeply into the vagina
After 7 days, it is steadily used for 2 ~ 3 days for 4 months.

Dosage & Administration

for vaginal use only

Package Label.Principal Display Panel

Label (Label)

Label (Label)

* Please review the disclaimer below.